Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
35M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
+4.5M
-
Total reported value, excl. options
-
$849M
-
Value change
-
+$223M
-
Number of buys
-
71
-
Number of sells
-
-20
-
Price
-
$44.40
Significant Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q2 2023
98 filings reported holding IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share as of Q2 2023.
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
of 35M outstanding shares and own 54.64% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (3.46M shares), ORBIMED ADVISORS LLC (2.27M shares), Bain Capital Life Sciences Investors, LLC (1.33M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.16M shares), Novo Holdings A/S (1.09M shares), PERCEPTIVE ADVISORS LLC (743K shares), Frazier Life Sciences Management, L.P. (655K shares), CITADEL ADVISORS LLC (651K shares), VANGUARD GROUP INC (560K shares), and BANK OF AMERICA CORP /DE/ (558K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.